Us Bancorp \De\ Taro Pharmaceutical Industries LTD Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$40.97 - $43.33 $3,031 - $3,206	-74 Reduced 32.17%	156 $6,000
Q4 2023 Feb 09, 2024	SELL	$32.77 - $42.31 $34,277 - $44,256	-1,046 Reduced 81.97%	230 $9,000
Q3 2023 Nov 03, 2023	SELL	$35.46 - $40.13 $250,595 - $283,598	-7,067 Reduced 84.71%	1,276 $48,000
Q2 2023 Aug 09, 2023	SELL	$24.24 - $40.97 $9,259 - $15,650	-382 Reduced 4.38%	8,343 $316,000
Q1 2023 May 09, 2023	SELL	$23.0 - $31.59 $644 - $884	-28 Reduced 0.32%	8,725 $212,000
Q4 2022 Feb 13, 2023	SELL	$27.6 - $32.99 $29,035 - $34,705	-1,052 Reduced 10.73%	8,753 $254,000
Q3 2022 Oct 27, 2022	SELL	$28.74 - $39.9 $8,219 - $11,411	-286 Reduced 2.83%	9,805 $295,000
Q2 2022 Aug 01, 2022	SELL	$35.0 - $43.59 $13,860 - $17,261	-396 Reduced 3.78%	10,091 $365,000
Q1 2022 May 11, 2022	BUY	$43.12 - $50.3 $19,145 - $22,333	444 Added 4.42%	10,487 $453,000
Q4 2021 Feb 11, 2022	SELL	$47.6 - $65.0 $31,082 - $42,445	-653 Reduced 6.11%	10,043 $502,000
Q3 2021 Nov 10, 2021	SELL	$62.34 - $73.38 $27,928 - $32,874	-448 Reduced 4.02%	10,696 $681,000
Q2 2021 Aug 05, 2021	SELL	$70.26 - $76.64 $21,288 - $23,221	-303 Reduced 2.65%	11,144 $801,000
Q1 2021 Apr 28, 2021	BUY	$70.48 - $79.95 $634 - $719	9 Added 0.08%	11,447 $844,000
Q4 2020 Feb 04, 2021	SELL	$54.4 - $73.42 $44,281 - $59,763	-814 Reduced 6.64%	11,438 $839,000
Q3 2020 Nov 10, 2020	SELL	$54.41 - $68.2 $2,666 - $3,341	-49 Reduced 0.4%	12,252 $673,000
Q2 2020 Aug 07, 2020	SELL	$61.66 - $70.16 $63,818 - $72,615	-1,035 Reduced 7.76%	12,301 $818,000
Q1 2020 May 13, 2020	SELL	$59.35 - $88.73 $64,394 - $96,272	-1,085 Reduced 7.52%	13,336 $817,000
Q4 2019 Feb 04, 2020	SELL	$74.18 - $97.92 $56,080 - $74,027	-756 Reduced 4.98%	14,421 $1.27 Million
Q3 2019 Nov 08, 2019	BUY	$75.36 - $86.57 $127,433 - $146,389	1,691 Added 12.54%	15,177 $1.15 Million
Q2 2019 Aug 13, 2019	BUY	$83.92 - $108.88 $371,010 - $481,358	4,421 Added 48.77%	13,486 $1.15 Million
Q1 2019 May 08, 2019	BUY	$85.97 - $108.09 $772,354 - $971,080	8,984 Added 11091.36%	9,065 $979,000
Q4 2018 Feb 13, 2019	BUY	$78.25 - $107.92 $2,582 - $3,561	33 Added 68.75%	81 $7,000
Q3 2018 Nov 01, 2018	SELL	$97.82 - $116.09 $6,456 - $7,661	-66 Reduced 57.89%	48 $5,000
Q2 2018 Aug 08, 2018	SELL	$97.62 - $120.59 $4,881 - $6,029	-50 Reduced 30.49%	114 $13,000
Q1 2018 May 08, 2018	SELL	$95.91 - $107.26 $78,166 - $87,416	-815 Reduced 83.25%	164 $16,000
Q4 2017 Feb 02, 2018	SELL	$104.5 - $126.38 $47,756 - $57,755	-457 Reduced 31.82%	979 $102,000
Q3 2017 Nov 13, 2017	BUY	$97.26 - $116.2 $139,665 - $166,863	1,436	1,436 $162,000

Others Institutions Holding TARO

# of Institutions

Shares Held

17K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account